PISANI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 5.434
EU - Europa 1.448
AS - Asia 715
SA - Sud America 71
AF - Africa 16
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.688
Nazione #
US - Stati Uniti d'America 5.412
IE - Irlanda 1.100
CN - Cina 398
SG - Singapore 262
IT - Italia 112
FI - Finlandia 83
DE - Germania 49
BR - Brasile 47
BE - Belgio 37
IN - India 22
CA - Canada 16
SE - Svezia 16
MU - Mauritius 14
RU - Federazione Russa 14
CO - Colombia 10
FR - Francia 10
GB - Regno Unito 7
HK - Hong Kong 6
AR - Argentina 5
CL - Cile 4
IR - Iran 4
NL - Olanda 4
UZ - Uzbekistan 4
AU - Australia 3
EC - Ecuador 3
MX - Messico 3
AT - Austria 2
ES - Italia 2
GR - Grecia 2
IQ - Iraq 2
JP - Giappone 2
MY - Malesia 2
PK - Pakistan 2
PT - Portogallo 2
TH - Thailandia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PL - Polonia 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
TR - Turchia 1
UA - Ucraina 1
Totale 7.688
Città #
Chandler 1.531
Dublin 1.096
Ashburn 552
Boardman 330
Princeton 297
Lawrence 288
Wilmington 282
Medford 178
Singapore 131
Fairfield 101
Ann Arbor 90
Helsinki 79
Shanghai 73
Falls Church 66
Norwalk 58
Washington 56
Seattle 49
Woodbridge 47
Los Angeles 42
Brussels 37
Beijing 36
Chicago 36
Santa Clara 22
Nanjing 20
Rome 20
Pune 19
Guangzhou 17
New York 13
Toronto 13
Shijiazhuang 9
Pavia 8
Shenyang 8
Falkenstein 7
Hangzhou 7
Jacksonville 7
Nanchang 7
Napoli 7
Zhengzhou 7
Changsha 6
Dallas 6
Hong Kong 6
Jinan 6
Munich 6
Palermo 6
Shenzhen 6
Harbin 5
Milan 5
Tianjin 5
Hebei 4
Houston 4
Manerbio 4
Medellín 4
Santiago 4
São Paulo 4
Tashkent 4
Valledupar 4
West Jordan 4
Wuhan 4
Zhongshan 4
Chongqing 3
Detroit 3
Dongguan 3
Guiyang 3
Jiaxing 3
Legnano 3
Lexington 3
Matino 3
Newark 3
Pontoglio 3
Porto Alegre 3
San Francisco 3
Azzano San Paolo 2
Barnsley 2
Bengaluru 2
Berazategui 2
Berlin 2
Canegrate 2
Chengdu 2
Clifton 2
Coyoacán 2
Dalian 2
Davoli 2
Edmonton 2
Eindhoven 2
Foshan 2
Hengyang 2
Huizhou 2
Jiangmen 2
Jinzhong 2
João Pessoa 2
Kunming 2
Lanzhou 2
Lisbon 2
Madrid 2
Montepaone Lido 2
Nardò 2
Ningbo 2
Nuremberg 2
Orlando 2
Phoenix 2
Totale 5.841
Nome #
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia 68
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of “organic” neurology 58
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 50
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission 48
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 47
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 46
The Effects of Intensive Neurorehabilitation on Sequence Effect in Parkinson's Disease Patients With and Without Freezing of Gait 45
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 43
Does acute peripheral trauma contribute to idiopathic adult-onset dystonia? 43
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 42
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 41
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 40
Impaired dopamine- and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia 40
Hypoxia-induced electrical changes in striatal neurons 40
Corticostriatal synaptic plasticity in PINK1 heterozygous mice: Effects of mitochondrial complex I inhibition 39
Dystonia 39
Demographic and clinical determinants of neck pain in idiopathic cervical dystonia 39
Dystonia as a network disorder: A concept in evolution 39
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 39
Physical Activity Changes and Correlate Effects in Patients with Parkinson's Disease during COVID-19 Lockdown 39
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus 38
Long-term treatment with rotigotine in drug-naïve PSP patients 38
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. I. Modulation of corticostriatal synaptic transmission 38
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 38
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice 37
Abnormal plasticity in dystonia: Disruption of synaptic homeostasis 37
Acetylcholine-mediated modulation of striatal function 37
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 37
Effects of two weeks of cerebellar theta burst stimulation in cervical dystonia patients 37
Enhanced mu opioid receptor–dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia 37
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 36
Optogenetic Activation of Striatopallidal Neurons Reveals Altered HCN Gating in DYT1 Dystonia 36
The international European Academy of Neurology survey on neurological symptoms in patients with COVID-19 infection 36
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 36
Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum 36
Mild mitochondrial impairment promotes corticostriatal synaptic plasticity alterations in PINK1 heterozygous knockout mice 35
The neuroligins and the synaptic pathway in Autism Spectrum Disorder 35
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 35
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 35
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 35
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease 35
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 34
Acanthocytosis as a predisposing factor non-ketotic hyperglycemia induced chorea-ballism 34
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 34
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 34
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia 34
Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia 34
Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons 34
A possible mechanism for the aglycemia-induced depression of glutamatergic excitation in the striatum 34
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 34
Metabotropic glutamate receptors and neuronal toxicity 33
Group 1 mGluR responses in distinct striatal interneuron subtypes 33
Tissue plasminogen activator is required for corticostriatal long-term potentiation 33
Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum 33
Pharmacological inhibition of the Na(+)/Ca(2+) exchanger enhances depolarizations induced by oxygen/glucose deprivation but not responses to excitatory amino acids in rat striatal neurons 33
Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones 33
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 33
Muscarinic IPSPs in rat striatal cholinergic interneurones 33
Deep brain stimulation in Parkinson's disease patients: biochemical evidence 32
Age-related functional changes of high-voltage-activated calcium channels in different neuronal subtypes of mouse striatum 32
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 32
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 32
Synaptic transmission in the striatum: from plasticity to neurodegeneration 32
Early abnormalities in 123I-ioflupane (DaTSCAN) imaging in the fragile X-associated tremor ataxia syndrome (FXTAS): a case report 32
Models of dystonia: an update 32
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 32
The neurobiological bases of autism spectrum disorders: the R451C-neuroligin 3 mutation hampers the expression of long-term synaptic depression in the dorsal striatum 32
Impaired striatal D2 receptor function leads to enhanced GABA transmission in a mouse model of DYT1 dystonia 32
Involvement of intracellular calcium stores during oxygen/glucose deprivation in striatal large aspiny interneurons 32
Deep learning and machine learning-based voice analysis for the detection of COVID-19: A proposal and comparison of architectures 31
Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia 31
Felbamate inhibits dihydropyridine-sensitive calcium channels in central neurons 31
Pedunculopontine nucleus deep brain stimulation changes spinal cord excitability in Parkinson's disease patients 31
Dopaminergic involvement in a drummer with focal dystonia: A case study 31
Lithium treatment blocks long-term synaptic depression in the striatum 31
Heterogeneity of metabotropic glutamate receptors in the striatum: electrophysiological evidence 31
L-type Ca2+ channel blockers attenuate electrical changes and Ca2+ rise induced by oxygen/glucose deprivation in cortical neurons 31
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology 31
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 31
Chorea Associated with JAK2V617F-Positive Essential Thrombocythemia 30
Hypoxia in striatal and cortical neurones: membrane potential and Ca2+ measurements 30
Compliance with levodopa-carbidopa intestinal gel in a selected population in central south Italy: Beyond sex, a possible gender effect 30
Amyloid-β42/Neurogranin Ratio as a Potential Index for Cognitive Impairment in Parkinson's Disease 30
Role of dopamine receptors in the short- and long-term regulation of corticostriatal transmission 30
Wearable electronics assess the effectiveness of transcranial direct current stimulation on balance and gait in Parkinson’s disease patients 30
Abnormal striatal plasticity in a DYT11/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition 30
Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment 30
Role of tonically-active neurons in the control of striatal function: cellular mechanisms and behavioral correlates 30
Double hit mouse model of Parkinson's disease 30
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 30
Sodium influx plays a major role in the membrane depolarization induced by oxygen and glucose deprivation in rat striatal spiny neurons 30
Outward potassium currents activated by depolarization in rat globus pallidus 30
Facemasks and face recognition: Potential impact on synaptic plasticity 30
Promising rodent models in Parkinson's disease 29
Mitochondrial toxins in Basal Ganglia disorders: from animal models to therapeutic strategies 29
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease 29
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia 29
Generation of a novel rodent model for DYT1 dystonia 29
Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission 29
Presynaptic modulation by group III metabotropic glutamate receptors (mGluRs) of the excitatory postsynaptic potential mediated by mGluR1 in rat cerebellar Purkinje cells 29
Totale 3.504
Categoria #
all - tutte 57.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204 0 0 0 0 0 0 0 0 0 3 1 0
2020/2021623 0 0 0 0 286 7 4 258 6 7 31 24
2021/20221.152 21 5 9 11 32 47 42 100 91 18 162 614
2022/20233.635 367 170 63 396 289 461 11 264 1.425 27 95 67
2023/20241.443 152 227 84 101 159 449 64 70 10 63 35 29
2024/20251.130 102 359 100 174 149 246 0 0 0 0 0 0
Totale 8.055